Substituted pyrrolopyrimidines and processes for their preparation
US6180636A · kind A · utility
51Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 1999 |
| Grant date | Jan 30, 2001 |
| Priority date | — |
| Expiry date | Feb 19, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are described 7H-pyrrolo[2,3-d]pyrimidine derivatives of the formula I ##STR1## in which the substituents are as defined in claim 1. These compounds inhibit the tyrosine kinase activity of the receptor for the epidermal growth factor (EGF) and c-erbB2 kinase and can be used as anti-tumor agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.